Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice
Meilin Wu, … , Joshua B. Plotkin, Jonathan A. Epstein
Meilin Wu, … , Joshua B. Plotkin, Jonathan A. Epstein
Published May 15, 2008
Citation Information: J Clin Invest. 2008;118(6):2076-2087. https://doi.org/10.1172/JCI33715.
View: Text | PDF
Research Article Development

Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice

  • Text
  • PDF
Abstract

Transcription factors regulate tissue patterning and cell fate determination during development; however, expression of early regulators frequently abates upon differentiation, suggesting that they may also play a role in maintaining an undifferentiated phenotype. The transcription factor paired box 3 (Pax3) is expressed by multipotent neural crest precursors and is implicated in neural crest disorders in humans such as Waardenburg syndrome. Pax3 is required for development of multiple neural crest lineages and for activation of lineage-specific programs, yet expression is generally extinguished once neural crest cells migrate from the dorsal neural tube and differentiate. Using a murine Cre-inducible system, we asked whether persistent Pax3 expression in neural crest derivatives would affect development or patterning. We found that persistent expression of Pax3 in cranial neural crest cells resulted in cleft palate, ocular defects, malformation of the sphenoid bone, and perinatal lethality. Furthermore, we demonstrated that Pax3 directly regulates expression of Sostdc1, a soluble inhibitor of bone morphogenetic protein (BMP) signaling. Persistent Pax3 expression renders the cranial crest resistant to BMP-induced osteogenesis. Thus, one mechanism by which Pax3 maintains the undifferentiated state of neural crest mesenchyme may be to block responsiveness to differentiation signals from the environment. These studies provide in vivo evidence for the importance of Pax3 downregulation during differentiation of multipotent neural crest precursors and cranial development.

Authors

Meilin Wu, Jun Li, Kurt A. Engleka, Bo Zhou, Min Min Lu, Joshua B. Plotkin, Jonathan A. Epstein

×

Figure 7

Pax3 binds the Sostdc1 promoter and decreases BMP-2 responsiveness.

Options: View larger image (or click on image) Download as PowerPoint
Pax3 binds the Sostdc1 promoter and decreases BMP-2 responsiveness.
(A) ...
(A) Electrophoretic mobility shift assay with radiolabeled probes for the proximal (–590) and distal (–3075) putative Pax3-binding motifs. Increasing amounts of nuclear extracts from Pax3-transfected 293T cells results in increased binding to both probes. Bands in first lane represent nonspecific binding. (B) Incubation with unlabeled competitor containing a Pax3-binding site (Pax3) or unlabeled proximal (–590) motif competitor reduces Pax3 binding to the proximal (–590) probe. A mutated proximal competitor (–590 Mut) competes poorly. Bands in the first lane represent nonspecific binding. Relative pixel densities of bands are indicated. (C) Immunoprecipitation of Sostdc1 promoter fragments containing either the distal or the proximal putative Pax3-binding motif are detected (lane 1, top and center panels) but not the Pax3 expression plasmid negative control (bottom panel). ChIP with control IgG1 demonstrates the specificity of the immunoprecipitation. IgG (lane 2) serves as a negative control. 293T lysate (+, lane 3) was used as a positive control. (D) Western blot to detect phosphorylated Smad1/5/8 or RNA polymerase II as loading control in nuclear extracts of primary palate cells treated with increasing doses of BMP-2. Lanes 1–5, control Pax3Cre/+, R26+/+ cells with control-conditioned medium (CM:+/+); lanes 6–10, Pax3Cre/+, R26Pax3/Pax3 cells with Pax3Cre/+, R26Pax3/Pax3–conditioned medium (CM:P3/P3); right panel, control cells with Pax3Cre/+, R26Pax3/Pax3–conditioned medium. (E) Western blot of nuclear extracts from wild-type primary palate cells treated with conditioned medium from control or myc-Sostdc1–transfected 293T cells and increasing doses of BMP-2. RIght panel demonstrates presence of myc-tagged Sostdc1 in conditioned medium from transfected cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts